The Ribosome Binding Site of Hepatitis C Virus mRNA
AUTOR(ES)
Lytle, J. Robin
FONTE
American Society for Microbiology
RESUMO
Hepatitis C virus (HCV) infects an estimated 170 million people worldwide, the majority of whom develop a chronic infection which can lead to severe liver disease, and for which no generally effective treatment yet exists. A promising target for treatment is the internal ribosome entry site (IRES) of HCV, a highly conserved domain within a highly variable RNA. Never before have the ribosome binding sites of any IRES domains, cellular or viral, been directly characterized. Here, we reveal that the HCV IRES sequences most closely associated with 80S ribosomes during protein synthesis initiation are a series of discontinuous domains together comprising by far the largest ribosome binding site yet discovered.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=114998Documentos Relacionados
- Cytoplasmic Expression of mRNAs Containing the Internal Ribosome Entry Site and 3′ Noncoding Region of Hepatitis C Virus: Effects of the 3′ Leader on mRNA Translation and mRNA Stability
- Internal ribosome entry site within hepatitis C virus RNA.
- Origin of Hepatitis Delta Virus mRNA
- Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes.
- Unusual ribosome binding properties of mRNA encoding bacteriophage lambda repressor.